Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299702
Status:
COMPLETED
Last Update Posted:
2011-12-30
First Post:
2006-03-03
Brief Title:
Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-year Period in Patients With Schizophrenia
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Organization Data
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Class:
INDUSTRY
Study ID:
CR006121
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Vice President Medical Affairs
Old Organization:
Ortho-McNeil Janssen Scientific Affairs LLC
Collaborators
| Name | Class |
|---|---|
| Janssen LP | INDUSTRY |